CITIGROUP INC - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 116 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$1,378,000
-21.3%
228,535
-53.0%
0.00%
-100.0%
Q3 2019$1,750,000
+78.0%
485,836
+32.5%
0.00%0.0%
Q2 2019$983,000
+361.5%
366,796
+411.0%
0.00%
Q1 2019$213,000
-68.8%
71,784
-83.3%
0.00%
-100.0%
Q4 2018$683,000
-27.7%
429,930
+67.5%
0.00%0.0%
Q3 2018$945,000
+60.7%
256,664
+23.5%
0.00%
Q2 2018$588,000
-26.8%
207,807
-4.1%
0.00%
-100.0%
Q1 2018$803,000
-19.9%
216,610
-37.8%
0.00%0.0%
Q4 2017$1,002,000
+21.7%
348,040
+90.1%
0.00%
Q3 2017$823,000
+23.9%
183,122
+26.8%
0.00%
Q2 2017$664,000
+14.5%
144,431
+4.7%
0.00%
Q1 2017$580,000
-76.2%
137,954
-76.6%
0.00%
-100.0%
Q4 2016$2,438,000
+227.2%
590,113
+541.1%
0.00%
Q3 2016$745,000
+21.7%
92,045
+17.3%
0.00%
Q2 2016$612,000
-56.2%
78,453
-56.6%
0.00%
-100.0%
Q1 2016$1,396,000
+7.2%
180,831
+49.9%
0.00%
+100.0%
Q4 2015$1,302,000
+40.6%
120,599
-9.9%
0.00%0.0%
Q3 2015$926,000
-9.6%
133,908
+15.9%
0.00%
Q2 2015$1,024,000
-16.1%
115,579
-6.5%
0.00%
-100.0%
Q1 2015$1,220,000
+18.0%
123,669
+46.5%
0.00%0.0%
Q4 2014$1,034,000
+430.3%
84,436
+332.3%
0.00%
Q3 2014$195,000
-16.7%
19,533
-36.7%
0.00%
Q2 2014$234,000
+91.8%
30,856
-16.9%
0.00%
Q1 2014$122,000
-29.5%
37,136
-28.8%
0.00%
Q4 2013$173,000
+61.7%
52,124
+47.2%
0.00%
Q3 2013$107,000
+105.8%
35,406
+466.2%
0.00%
Q2 2013$52,0006,2530.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q2 2014
NameSharesValueWeighting ↓
RA Capital Management 13,633,220$56,305,0007.98%
BVF INC/IL 2,423,300$10,008,0002.01%
EMORY UNIVERSITY 454,102$1,875,0001.85%
DAFNA Capital Management LLC 196,500$812,0000.71%
Orbimed Advisors 13,107,200$54,133,0000.69%
RTW INVESTMENTS, LP 286,285$1,182,0000.44%
Marcus Capital, LLC 100,000$413,0000.44%
Rock Springs Capital Management LP 1,375,000$5,679,0000.38%
Spark Investment Management LLC 978,600$4,041,0000.33%
Bellevue Group AG 240,000$991,0000.20%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders